HuGE Literature Finder
Records 1-30
|
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms.
Hematology, transfusion and cell therapy 2019 Oct . Porto-Soares Moysés Antonio, de Oliveira Rafael Daltro, Cortopassi Gabriel Macedo, Machado-Neto João Agostinho, Palma Leonardo Carvalho, Figueiredo-Pontes Lorena Lobo |
|
TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients.
International journal of hematology 2019 Sep . Matsuguma Masafumi, Yujiri Toshiaki, Yamamoto Kaoru, Kajimura Yasuko, Tokunaga Yoshihiro, Tanaka Mayumi, Tanaka Yoshinori, Nakamura Yukinori, Tanizawa Yuk |
|
[Detection and Diagnostic Values of JAK2, CALR, MPL Gene Mutations in 208 Cases of BCR/ABL1 Negative Chronic Myeloproliferative Diseases].
Zhongguo shi yan xue ye xue za zhi 2018 Aug 26 (4): 1122-1128. Li Zhen-Ling, Gao Li, Zhang Hui, Zhang Chun-Xia, Chen Yan-Rong, Huang Fan-Zhou, Gong Ming, Gao Ya-Yue, Tang Yin, Ma Yi-G |
|
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors.
Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
|
GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms.
Annals of laboratory medicine 2018 Jul 38 (4): 296-305. Yang Naery, Park Sholhui, Cho Min Sun, Lee Miae, Hong Ki Sook, Mun Yeung Chul, Seong Chu Myong, Huh Hee Jin, Huh Jungw |
|
Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.
International journal of hematology 2018 Feb . Misawa Kyohei, Yasuda Hajime, Araki Marito, Ochiai Tomonori, Morishita Soji, Shirane Shuichi, Edahiro Yoko, Gotoh Akihiko, Ohsaka Akimichi, Komatsu Nor |
|
Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center.
Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
|
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.
Hematology (Amsterdam, Netherlands) 2017 Oct 1-4. Ojeda Mara Jorgelina, Bragós Irma Margarita, Calvo Karina Lucrecia, Williams Gladis Marcela, Carbonell María Magdalena, Pratti Arianna Flav |
|
MECOM, HBS1L-MYB, THRB-RARB, JAK2 and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms - a study on 939 patients.
American journal of hematology 2017 Oct . Trifa Adrian P, B?nescu Claudia, Bojan Anca S, Voina Cristian M, Popa ?tefana, Vi?an Simona, Ciubean Alina D, Tripon Florin, Dima Delia, Popov Viola M, Vesa ?tefan C, Andreescu Mihaela, Török-Vistai Tünde, Mih?il? Romeo G, Berbec Nicoleta, Macarie Ioan, Coli?? Andrei, Iordache Maria, C?tan? Alina C, Farca? Marius F, Tomuleasa Ciprian, Vasile Kinga, Truic? Cristina, Todinc? Adriana, Pop-Muntean Lavinia, Manolache Raluca, Bumbea Horia, Vl?d?reanu Ana-Maria, Gaman Mihaela, Ciufu Cristina M, Popp Radu |
|
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms.
Medical oncology (Northwood, London, England) 2017 May 34 (5): 83. Chang Yu-Cheng, Lin Huan-Chau, Chiang Yi-Hao, Chen Caleb Gon-Shen, Huang Ling, Wang Wei-Ting, Cheng Chun-Chia, Lin Johnson, Chang Yi-Fang, Chang Ming-Chih, Hsieh Ruey-Kuen, Chen Shu-Jen, Lim Ken-Hong, Kuo Yuan-Y |
|
Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.
Hematology (Amsterdam, Netherlands) 2017 Apr 1-8. Limsuwanachot N, Rerkamnuaychoke B, Chuncharunee S, Pauwilai T, Singdong R, Rujirachaivej P, Chareonsirisuthigul T, Siriboonpiputtana |
|
Sequential Analysis of 18 Genes in Polycythemia Vera and Essential Thrombocythemia Reveals an Association between Mutational Status and Clinical Outcome.
Genes, chromosomes & cancer 2016 Dec . Luque Paz Damien, Chauveau Aurélie, Boyer Françoise, Buors Caroline, Samaison Laura, Cottin Laurane, Seegers Valérie, Férec Claude, Le Maréchal Cédric, Gueguen Paul, Lippert Eric, Ianotto Jean-Christophe, Ugo Valér |
|
Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms.
Hematology (Amsterdam, Netherlands) 2016 Oct 21 (9): 520-5. Trifa Adrian P, Banescu Claudia, Dima Delia, Bojan Anca S, Tevet Mihaela, Moldovan Valeriu G, Vesa ?tefan C, Murat Meilin, Pop Ioan V, Skrypnyk Cristina, Popp Radu |
|
Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2016 Jun 32 (Suppl 1): 112-6. Rashid Munazza, Ahmed Rifat Zubair, Ahmed Shariq, Nadeem Muhammad, Ahmed Nuzhat, Shamsi Tahir Sult |
|
Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patiets.
Journal of clinical laboratory analysis 2016 May . Yoo Eun-Hyung, Park Kyung-Jin, Won Hong-Hee, Park Jun-Hee, Park Jong-Ho, Lee Seung-Tae, Kim Hee-Jin, Bang Soo-Mee, Chi Hyun-Sook, Jung Chul Won, Kim Sun-Hee, Yun Hongseok, Sun Choong-Hyun, Park Inho, Lee Seungmook, Lee Clarence, Merriman Barry, Luo Raymond, Tan Eileen Hwee Hong, Park Keun-Joon, Yoo Na-Kyung, Kang Jason J, Kim Jong-W |
|
Molecular biomarkers of thrombosis in myeloproliferative neoplasms.
Thrombosis research 2016 Apr 140 Suppl 1 S71-5. Barbui Tiziano, Falanga An |
|
Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 923-6. Ahmed Rifat Zubair, Rashid Munazza, Ahmed Nuzhat, Nadeem Muhammad, Shamsi Tahir Sult |
|
Presence of atypical thrombopoietin receptor (MPL) mutations in triple negative essential thrombocythemia patients.
Blood 2015 Oct . Cabagnols Xénia, Favale Fabrizia, Pasquier Florence, Messaoudi Kahia, Defour Jean Philippe, Ianotto Jean Christophe, Marzac Christophe, Le Couédic Jean Pierre, Droin Nathalie, Chachoua Ilyas, Favier Remi, Diop M'boyba Khadija, Ugo Valérie, Casadevall Nicole, Debili Najet, Raslova Hana, Bellanne-Chantelot Christine, Constantinescu Stefan N, Bluteau Olivier, Plo Isabelle, Vainchenker Willi |
|
The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.
American journal of clinical pathology 2015 Jul 144 (1): 165-71. Lin Yani, Liu Enbin, Sun Qi, Ma Jiao, Li QingHua, Cao Zeng, Wang Jun, Jia Yujiao, Zhang Hongju, Song Zhen, Ai Xiaofei, Shi Lihui, Feng Xiaofang, Li Chenwei, Wang Jianxiang, Ru K |
|
No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation.
Blood cells, molecules & diseases 2015 Jun 55 (1): 36-9. Gau Jyh-Pyng, Chen Chih-Cheng, Chou Yi-Sheng, Liu Chia-Jen, Yu Yuan-Bin, Hsiao Liang-Tsai, Liu Jin-Hwang, Hsu Hui-Chi, Chiou Tzeon-Jye, Chen Po-Min, Tzeng Cheng-Hw |
|
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Leukemia research 2015 May 39 (5): 525-9. Gianelli Umberto, Iurlo Alessandra, Cattaneo Daniele, Bossi Anna, Cortinovis Ivan, Augello Claudia, Moro Alessia, Savi Federica, Castelli Roberto, Brambilla Cecilia, Bianchi Paola, Primignani Massimo, Cortelezzi Agostino, Bosari Silva |
|
Calreticulin exon 9 mutations in myeloproliferative neoplasms.
Annals of laboratory medicine 2015 Jan 35 (1): 22-7. Ha Jung-Sook, Kim Yu-Kyu |
|
Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.
PloS one 2015 10 (9): e0138250. Guo Haixiu, Chen Xiuhua, Tian Ruiyuan, Chang Jianmei, Li Jianlan, Tan Yanhong, Xu Zhifang, Ren Fanggang, Zhao Junxia, Pan Jie, Zhang Na, Wang Xiaojuan, He Jianxia, Yang Wanfang, Wang Hongw |
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms.
Nature communications 2015 6 6691. Tapper William, Jones Amy V, Kralovics Robert, Harutyunyan Ashot S, Zoi Katerina, Leung William, Godfrey Anna L, Guglielmelli Paola, Callaway Alison, Ward Daniel, Aranaz Paula, White Helen E, Waghorn Katherine, Lin Feng, Chase Andrew, Baxter E Joanna, Maclean Cathy, Nangalia Jyoti, Chen Edwin, Evans Paul, Short Michael, Jack Andrew, Wallis Louise, Oscier David, Duncombe Andrew S, Schuh Anna, Mead Adam J, Griffiths Michael, Ewing Joanne, Gale Rosemary E, Schnittger Susanne, Haferlach Torsten, Stegelmann Frank, Döhner Konstanze, Grallert Harald, Strauch Konstantin, Tanaka Toshiko, Bandinelli Stefania, Giannopoulos Andreas, Pieri Lisa, Mannarelli Carmela, Gisslinger Heinz, Barosi Giovanni, Cazzola Mario, Reiter Andreas, Harrison Claire, Campbell Peter, Green Anthony R, Vannucchi Alessandro, Cross Nicholas C |
|
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.
Blood 2014 Oct 124 (16): 2507-13; quiz 2615. Tefferi Ayalew, Guglielmelli Paola, Larson Dirk R, Finke Christy, Wassie Emnet A, Pieri Lisa, Gangat Naseema, Fjerza Rajmonda, Belachew Alem A, Lasho Terra L, Ketterling Rhett P, Hanson Curtis A, Rambaldi Alessandro, Finazzi Guido, Thiele Juergen, Barbui Tiziano, Pardanani Animesh, Vannucchi Alessandro |
|
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.
Blood 2014 Apr 123 (15): 2416-9. Rumi Elisa, Harutyunyan Ashot S, Pietra Daniela, Milosevic Jelena D, Casetti Ilaria C, Bellini Marta, Them Nicole C C, Cavalloni Chiara, Ferretti Virginia V, Milanesi Chiara, Berg Tiina, Sant'Antonio Emanuela, Boveri Emanuela, Pascutto Cristiana, Astori Cesare, Kralovics Robert, Cazzola Mario, |
|
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Blood 2014 Mar 123 (10): 1544-51. Rumi Elisa, Pietra Daniela, Ferretti Virginia, Klampfl Thorsten, Harutyunyan Ashot S, Milosevic Jelena D, Them Nicole C C, Berg Tiina, Elena Chiara, Casetti Ilaria C, Milanesi Chiara, Sant'antonio Emanuela, Bellini Marta, Fugazza Elena, Renna Maria C, Boveri Emanuela, Astori Cesare, Pascutto Cristiana, Kralovics Robert, Cazzola Mario, |
|
The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
Journal of hematology & oncology 2014 7 48. Wu Zhiyuan, Zhang Xinju, Xu Xiao, Chen Yuming, Hu Tingting, Kang Zhihua, Li Shibao, Wang Hua, Liu Weiwei, Ma Xiaochao, Guan Mi |
|
Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature.
Thrombosis and haemostasis 2013 May 109 (5): 878-84. Qi X, Wu F, Ren W, He C, Yin Z, Niu J, Bai M, Yang Z, Wu K, Fan D, Han |
|
Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India.
Indian journal of pathology & microbiology 0 61 (2): 209-213. Rabade Nikhil, Subramanian P G, Kodgule Rohan, Raval Goutham, Joshi Swapnali, Chaudhary Shruti, Mascarenhas Russel, Tembhare Prashant, Gujral Sumeet, Patkar Nikh |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 23, 2020
- Content source: